Clinical trial · Observational
Patient Reported Outcomes Following Percutaneous Lung Ablation
NCT07720102CI-TRIAL-00118960not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Neoplasm | Lung Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Non-Interventional Study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational
- description
- Patients complete surveys throughout the study.
- interventionNames
- Other: Non-Interventional Study
Primary outcomes (1)
- measure
- Symptom severity following percutaneous lung ablation
- timeFrame
- Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months
- description
- Assessed using a study-specific survey. Participants evaluate 5 symptoms (pain, fatigue, drowsiness, shortness of breath, and disturbed sleep), each on an 11-point Likert scale of 0-10 where 0=absence of symptoms and 10=as bas as you can imagine. Higher scores indicate greater severity of symptoms.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Undergoing percutaneous lung ablation Exclusion Criteria: * Decline to participate in research
References
Publications (0)
Data not yet available
No reference posted for this study.